Phases précoces tumeurs solides
INDUCE-1 (GSK-204691)
A Phase I Open Label Study of GSK3359609 Administered Alone and in Combination With Anticancer Agents in Subjects With Selected Advanced Solid Tumors
Paris
CHRISTOPHE LE TOURNEAU